Logo image of ORMP

ORAMED PHARMACEUTICALS INC (ORMP) Stock Analyst Ratings

USA - NASDAQ:ORMP - US68403P2039 - Common Stock

2.24 USD
-0.04 (-1.75%)
Last: 11/5/2025, 8:21:38 PM
2.1909 USD
-0.05 (-2.19%)
After Hours: 11/5/2025, 8:21:38 PM
Buy % Consensus

43

ChartMill assigns a Buy % Consensus number of 43% to ORMP. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 3.32. This target is 47.99% above the current price.
ORMP was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about ORMP.
In the previous month the buy percentage consensus was at a similar level.
ORMP was analyzed by 6 analysts. More opinions would make the average more meaningful.

Related screens

ORMP Historical Analyst RatingsORMP Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -100 -91 -82 -73 -64 -55 -46 -37 -28 -19 -10 -1 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 2.243.283.323.323.41 - 46.54% 47.99% 47.99% 52.34%

Related screens

ORMP Current Analyst RatingORMP Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2024-09-09 HC Wainwright & Co. Reiterate Neutral
2024-05-20 HC Wainwright & Co. Reiterate Neutral
2023-05-17 Canaccord Genuity Maintains Hold -> Hold
2023-01-17 HC Wainwright & Co. Downgrade Buy -> Neutral
2023-01-12 Canaccord Genuity Downgrade Buy -> Hold
2022-05-16 Aegis Capital Maintains Buy
2022-02-18 Cantor Fitzgerald Initiate Overweight
2021-11-30 HC Wainwright & Co. Maintains Buy
2021-11-29 HC Wainwright & Co. Maintains Buy
2021-11-02 Aegis Capital Maintains Buy
2021-07-29 Canaccord Genuity Maintains Buy
2021-06-08 Aegis Capital Maintains Buy
2021-04-20 Canaccord Genuity Initiate Buy
2021-02-09 National Securities Corporation Initiate Buy

ORAMED PHARMACEUTICALS INC / ORMP FAQ

Can you provide the average price target for ORAMED PHARMACEUTICALS INC stock?

6 analysts have analysed ORMP and the average price target is 3.32 USD. This implies a price increase of 47.99% is expected in the next year compared to the current price of 2.24.


What is the consensus rating for ORAMED PHARMACEUTICALS INC (ORMP) stock?

The consensus rating for ORAMED PHARMACEUTICALS INC (ORMP) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.